Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

STRIVE Post-Market Registry Study

NCT: NCT04302272 · RECRUITING

NCT IDNCT04302272
StatusRECRUITING
Start Date2021-10-09
Completion2029-10

Brief Summary

This is a single-arm, prospective, multi-center, Registry study to evaluate the long-term safety and effectiveness of the Spiration Valve System (SVS) for the treatment of severe emphysema in a post-market setting.

Frequently Asked Questions

What is STRIVE Post-Market Registry Study?

STRIVE Post-Market Registry Study is a clinical trial registered under NCT04302272. Current status: RECRUITING.

What is the status of NCT04302272?

The current status of NCT04302272 (STRIVE Post-Market Registry Study) is: RECRUITING.

When did STRIVE Post-Market Registry Study start?

STRIVE Post-Market Registry Study started on 2021-10-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.